Mycophenolate mofetil-induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report.

Minoo Moghimi Zahra Nekoukar Farhad Gholami

Published in: Clinical case reports (2021)

Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66-year-old male MGN case treated with MMF and revealed acquired sensory-motor axonal polyneuropathy, which is rare and has not been reported before.

Keyphrases

high glucose
spinal cord injury
diabetic rats
single cell
drug induced
oxidative stress
combination therapy
endothelial cells